Photo of Herminia (Diana) Diana Rosas, MD

Herminia (Diana) Diana Rosas, MD

  • Director, Center for Neuro-imaging of Aging and Neurodegenerative Disease


Accepting New Patients




Clinical Interests
  • Huntington's disease
  • Alzheimer's disease
Medical Education
  • MD, University of Chicago Pritzker School of Medicine
  • Residency, Massachusetts General Hospital
Board Certifications
  • Neurology
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - New York
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile

Research & Publications

Research Summary
Dr. Rosas and her team have focused primarily on the development of biomarkers for use in the study of neurodegenerative diseases, to better characterize progression, to better understand genotype/phenotype correlations, and to apply novel neuroimaging approaches in clinical trials with the overall aim of making them more efficient. We have begun to develop models that may explain clinically heterogeneous phenotypes and variability in disease progression. The current models for both disease prediction and prediction of disease progression are insensitive and inaccurate. We are planning to expand our efforts to include multi-modal and multi-spectral imaging approaches that promise both more precise measurements and made provide novel and important information on the neural underpinnings of HD and their clinical consequences.

View my most recent publications at PubMed

1.Rosas HD, Zaleta AK, Lee SY, Pappu V, Salat DH, Hersch SM (2008) Complexity and heterogeneity: The role of the cortex in the clinical expression of HDN Brain Apr 131: 1057-68.3.Rosas HD, LeeSY, BenderAC, ZaletaAK, VangelM, YuP, FischlB, PappuV,OnoratoC, ChaJH,Salat DH,Hersch S. Altered white matter microstructure inthe corpus callosum in Huntingto?s disease: implications for cortical*disconnection. (2010)NeuroImage.49; 2995-3. 4.SalatDH, ChenJJ, vanderKouwe AJ, GreveDN, FischlB, RosasHD.Hippocampal degeneration is associated with temporal and limbic gray/whitematter tissue contrast in Alzheimers disease.(2011)NeuroImage; 54,1795-802. 5.Rosas HD, ReuterM, DorosG, LeeSY, TriggsTT, MalarickK,Fischl B,Salat DH,HerschSM. A Tale of Two Factors: What better determines rate of progressionin HD, age or CAG repeat?(2010) Movement Disorders.

Edit Profile

News & Events


Neurology Associates
15 Parkman Street
Boston MA, 02114-3117
Phone: 617-726-1728617-726-5532
Fax: 617-726-4101

Edit Profile

Back to Top